fda halts glp-1 Compound versions of drugs for weight loss halted by Compounded" GLP-1 drugs | Health

Nonetheless, the labeled nuclide in MEN-1 continues to be 68Ga

Important Note Persistent vomiting, severe abdominal pain, or symptoms of pancreatitis require immediate medical evaluation

PMCID: PMC6683038

Keep in mind: For patients starting GLP-1 therapy, this lack of clarity matters

Saxenda Dosing Saxenda requires daily subcutaneous injection: Titration schedule: Administration: Inject once daily at any time Consistent timing recommended Abdomen, thigh, or upper arm injection sites Rotate sites to prevent irritation Practical burden: 365 injections per year Must remember daily More needle/supply use Higher chance of missed doses Semaglutide Dosing Semaglutide requires weekly subcutaneous injection: Titration schedule (Wegovy doses): Administration: Inject once weekly on the same day each week Any time of day Same injection sites as Saxenda Rotate sites Practical burden: 52 injections per year Weekly reminder easier than daily Less needle/supply use Better adherence typically Dosing Comparison Impact on Adherence Research consistently shows better adherence with weekly versus daily medications: Daily dosing challenges: Easier to forget More disruption to routines Higher cumulative burden Greater chance of inconsistent dosing Weekly dosing advantages: Easier to remember one day Less intrusion on daily life Can establish reliable routine Fewer opportunities to miss doses Better adherence translates to better real-world results